# IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

> **NCT01232361** · — · COMPLETED · sponsor: **International Maternal Pediatric Adolescent AIDS Clinical Trials Group** · enrollment: 127 (actual)

## Conditions studied

- ADHD
- HIV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01232361
- **Lead sponsor:** International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2021-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01232361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01232361, "IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01232361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*